Follow The Filings

Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

  • $21.7B
  • 77 holdings
  • 2026 Q2
  • +23.6% QoQ
  • Top 5 29.9%

Farallon Capital Management's biggest moves in 2026 Q2 were opening Electronic Arts and Parabilis Medicines, adding to Immunovant and Roivant Sciences, trimming Revolution Medicines and Microsoft, and selling out of Charles Schwab and Alphabet.

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

  1. RVMD, Revolution Medicines 11.7%
  2. EA, Electronic Arts 7.5%
  3. BBIO, Bridgebio 3.7%
  4. PTGX, Protagonist Therapeutics 3.6%
  5. EXEL, Exelixis 3.4%
  6. LQDA, Liquidia 3.1%
  7. AMZN, Amazon 2.9%
  8. LNTH, Lantheus 2.9%
  9. NTRA, Natera 2.8%
  10. UNH, UnitedHealth Group 2.4%
  11. TMO, Thermo Fisher Scientific 2.4%
  12. ROIV, Roivant Sciences 2.3%
  13. Other 51.3%

AUM over time

2026 Q2 $21.7B +23.6% QoQ
2021 Q3: $19.7B 2021 Q3: $19.7B
Q3 2021
2021 Q4: $18.7B, −5.1% QoQ 2021 Q4: $18.7B, −5.1% QoQ
Q4
2022 Q1: $18.8B, +0.4% QoQ 2022 Q1: $18.8B, +0.4% QoQ
Q1 2022
2022 Q2: $16.3B, −13.7% QoQ 2022 Q2: $16.3B, −13.7% QoQ
Q2
2022 Q3: $16.8B, +3.5% QoQ 2022 Q3: $16.8B, +3.5% QoQ
Q3
2022 Q4: $15.3B, −9.3% QoQ 2022 Q4: $15.3B, −9.3% QoQ
Q4
2023 Q1: $17.7B, +15.8% QoQ 2023 Q1: $17.7B, +15.8% QoQ
Q1 2023
2023 Q2: $17.9B, +1.3% QoQ 2023 Q2: $17.9B, +1.3% QoQ
Q2
2023 Q3: $20B, +11.5% QoQ 2023 Q3: $20B, +11.5% QoQ
Q3
2023 Q4: $20.1B, +1.0% QoQ 2023 Q4: $20.1B, +1.0% QoQ
Q4
2024 Q1: $22.1B, +9.8% QoQ 2024 Q1: $22.1B, +9.8% QoQ
Q1 2024
2024 Q2: $21.2B, −4.2% QoQ 2024 Q2: $21.2B, −4.2% QoQ
Q2
2024 Q3: $20.4B, −3.6% QoQ 2024 Q3: $20.4B, −3.6% QoQ
Q3
2024 Q4: $19.7B, −3.5% QoQ 2024 Q4: $19.7B, −3.5% QoQ
Q4
2025 Q1: $17.9B, −9.0% QoQ 2025 Q1: $17.9B, −9.0% QoQ
Q1 2025
2025 Q2: $23.2B, +29.2% QoQ 2025 Q2: $23.2B, +29.2% QoQ
Q2
2025 Q3: $24.4B, +5.4% QoQ 2025 Q3: $24.4B, +5.4% QoQ
Q3
2025 Q4: $21.2B, −13.2% QoQ 2025 Q4: $21.2B, −13.2% QoQ
Q4
2026 Q1: $17.5B, −17.2% QoQ 2026 Q1: $17.5B, −17.2% QoQ
Q1 2026
2026 Q2: $21.7B, +23.6% QoQ 2026 Q2: $21.7B, +23.6% QoQ
Q2

Latest book

2026 Q2 2026 Q1, filed 14 Aug, long equity only

Download CSV Download Excel All activity
RVMD, Revolution Medicines 11.71% Reduce −0.4% 13,550,796 $187.28 $2.5B −54,000 +$1.2B
EA, Electronic Arts 7.49% New 7,919,500 $205.04 $1.6B +7,919,500 +$1.6B
BBIO, Bridgebio 3.69% Add +14.7% 10,743,063 $74.48 $800M +1,377,600 +$105M
PTGX, Protagonist Therapeutics 3.59% Hold 6,348,906 $122.58 $778M — —
EXEL, Exelixis 3.38%, was 3.21% Add +2.7% 13,468,010 $54.41 $733M +357,000 +$170M
LQDA, Liquidia 3.08% Reduce −3.4% 8,365,038 $79.73 $667M −291,000 +$340M
AMZN, Amazon 2.90%, was 5.01% Reduce −37.6% 2,632,994 $238.34 $628M −1,585,400 −$251M
LNTH, Lantheus 2.86% Hold 5,583,479 $110.94 $619M — —
NTRA, Natera 2.78%, was 3.66% Reduce −30.8% 2,218,366 $271.45 $602M −989,000 −$39M
UNH, UnitedHealth Group 2.44%, was 2.81% Reduce −30.3% 1,270,532 $415.63 $528M −551,174 +$35M
TMO, Thermo Fisher Scientific 2.43% Add +19.0% 1,049,185 $501.36 $526M +167,700 +$93M
ROIV, Roivant Sciences 2.34%, was 1.53% Add +47.9% 14,309,000 $35.39 $506M +4,634,000 +$238M
AON, Aon 2.12%, was 4.62% Reduce −45.0% 1,382,562 $331.69 $459M −1,130,076 −$352M
BSX, Boston Scientific 2.07% Add +40.8% 10,521,184 $42.68 $449M +3,050,500 −$20M
AVGO, Broadcom 2.01%, was 3.14% Reduce −35.3% 1,151,800 $377.75 $435M −627,700 −$116M
MSFT, Microsoft 1.92%, was 4.95% Reduce −52.5% 1,112,863 $373.02 $415M −1,231,916 −$453M
TNGX, Tango Therapeutics 1.77%, was 1.08% Add +35.0% 12,277,000 $31.26 $384M +3,179,589 +$193M
KKR 1.74%, was 2.46% Reduce −11.8% 4,118,300 $91.78 $378M −553,500 −$54M
SNPS, Synopsys 1.71%, was 2.74% Reduce −31.6% 829,600 $446.07 $370M −383,700 −$111M
BEAM, Beam Therapeutics 1.62%, was 1.38% Add +1.0% 10,236,396 $34.32 $351M +101,700 +$110M
CRNX 1.55% Add +7.8% 8,989,098 $37.42 $336M +651,000 +$34M
GRAL, Grail 1.31%, was 0.96% Add +27.9% 4,161,584 $68.27 $284M +907,900 +$116M
WAB, Wabtec 1.11%, was 2.29% Reduce −44.4% 894,503 $269.60 $241M −714,900 −$161M
IMVT, Immunovant 1.03%, was 0.22% Add +275.5% 5,805,000 $38.53 $224M +4,259,000 +$185M
TWST, Twist Bioscience 1.01%, was 0.39% Add +49.6% 2,136,400 $102.88 $220M +708,750 +$152M
AGIO, Agios Pharmaceuticals 1.01% Add +4.1% 5,917,400 $37.11 $220M +233,400 +$27M
ARMK, Aramark 0.95%, was 1.42% Reduce −40.9% 3,625,731 $56.90 $206M −2,509,700 −$42M
BIDU, Baidu 0.63%, was 0.28% Add +171.3% 1,203,785 $114.29 $138M +760,000 +$88M
NVO, Novo Nordisk 0.58%, was 0.16% Add +234.9% 2,619,000 $47.94 $126M +1,837,000 +$97M
ACHC 0.58%, was 0.23% Add +143.0% 4,220,800 $29.53 $125M +2,484,000 +$84M
BTSG, Brightspring Health Services 0.56%, was 0.39% Add +7.2% 1,732,800 $69.74 $121M +115,800 +$52M
AZN, AstraZeneca 0.50%, was 0.25% Add +153.4% 574,000 $189.62 $109M +347,501 +$64M
JNJ, Johnson & Johnson 0.48%, was 0.21% Add +175.7% 408,000 $253.97 $104M +260,000 +$67M
PBLS, Parabilis Medicines 0.30% New 2,368,200 $27.37 $65M +2,368,200 +$65M
NVS, Novartis 0.26% New 363,000 $156.72 $57M +363,000 +$57M
GH, Guardant Health 0.22% Add +3927.5% 322,200 $150.03 $48M +314,200 +$48M
AVTX, Avalo Therapeutics 0.21%, was 0.08% Add +172.7% 2,498,000 $18.48 $46M +1,582,000 +$32M
JOYY 0.21%, was 0.19% Add +20.9% 699,200 $65.99 $46M +121,000 +$12M
ASMB, Assembly Biosciences 0.20%, was 0.19% Add +30.7% 1,604,590 $27.48 $44M +377,000 +$10M
ENTA, Enanta Pharmaceuticals 0.16%, was 0.21% Reduce −15.8% 2,418,202 $14.58 $35M −453,660 −$1M
MAZE, Maze Therapeutics 0.15%, was 0.06% Add +197.0% 1,107,814 $29.84 $33M +734,814 +$22M
MRK, Merck 0.12%, was 0.25% Reduce −44.9% 199,000 $128.50 $26M −162,000 −$18M
WRBY, Warby Parker 0.12% New 828,000 $30.34 $25M +828,000 +$25M
PCSC, Perceptive Cap Solutions 0.11% Hold 2,250,000 $10.88 $24M — —
KLRA, Kailera Therapeutics 0.11% New 1,100,000 $22.03 $24M +1,100,000 +$24M
RIO, Rio Tinto 0.08%, was 0.03% Add +241.0% 183,475 $94.93 $17M +129,675 +$12M
AXTA, Axalta Coating Systems 0.08% New 478,000 $34.22 $16M +478,000 +$16M
ABVX, Abivax 0.08% Add +6000.0% 122,000 $133.26 $16M +120,000 +$16M
VNET, Vnet Group 0.07%, was 0.03% Add +219.6% 1,992,000 $8.04 $16M +1,368,653 +$11M
NTES, NetEase 0.07%, was 0.19% Reduce −57.6% 123,500 $128.14 $16M −167,719 −$17M

Showing top 50 of 77 by value

Exits / last held

Gone since 2026 Q1, shown at their last reported size.

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
SCHW, Charles Schwab 2.12% Exit 0 $93.98 $372M −3,955,657 −$372M
GOOG, Alphabet 1.63% Exit 0 $286.86 $286M −996,231 −$286M
V, Visa 1.45% Exit 0 $302.24 $254M −840,710 −$254M
DIS, Disney 1.32% Exit 0 $96.38 $231M −2,401,591 −$231M
MA, Mastercard 1.24% Exit 0 $499.66 $217M −435,071 −$217M
MCK, McKesson 1.16% Exit 0 $865.36 $203M −234,300 −$203M
CNTA, Centessa Pharmaceuticals 1.09% Exit 0 $39.72 $191M −4,809,000 −$191M
TYRA, Tyra Biosciences 0.78% Exit 0 $38.30 $137M −3,580,818 −$137M
THC, Tenet Healthcare 0.49% Exit 0 $188.71 $85M −452,153 −$85M
CAH, Cardinal Health 0.44% Exit 0 $211.31 $78M −368,000 −$78M
PCVX, Vaxcyte 0.42% Exit 0 $58.11 $73M −1,261,000 −$73M
DNTH, Dianthus Therapeutics 0.40% Exit 0 $83.92 $70M −836,000 −$70M
CGON, CG Oncology 0.26% Exit 0 $67.68 $46M −674,000 −$46M
BITW, Bitwise 10 Crypto Index ETF 0.15% Exit 0 $44.61 $27M −603,000 −$27M
RPRX 0.13% Exit 0 $47.97 $24M −493,000 −$24M
CECO, Ceco Environmental 0.08% Exit 0 $59.58 $14M −234,000 −$14M
GDS, GDS Holdings 0.07% Exit 0 $40.29 $12M −292,000 −$12M
FORM, Formfactor 0.03% Exit 0 $96.99 $5.5M −56,500 −$5.5M
MTZ, Mastec 0.03% Exit 0 $321.76 $5.5M −17,000 −$5.5M
ENTG, Entegris 0.03% Exit 0 $117.23 $5.3M −45,500 −$5.3M
C, Citigroup 0.03% Exit 0 $113.40 $5.3M −47,000 −$5.3M
H, Hyatt Hotels 0.03% Exit 0 $143.78 $5.2M −36,000 −$5.2M
WST, Western Alliance Bancorp 0.03% Exit 0 $70.85 $5.2M −73,000 −$5.2M
TKR, Timken 0.03% Exit 0 $100.57 $5.1M −51,000 −$5.1M
FLEX, Flextronics International 0.03% Exit 0 $65.46 $5.1M −78,000 −$5.1M
SPGI, S&P Global 0.03% Exit 0 $425.33 $5.1M −12,000 −$5.1M
LFUS, Littelfuse 0.03% Exit 0 $339.33 $5.1M −15,000 −$5.1M
PIPR, Piper Sandler Companies 0.03% Exit 0 $76.55 $5.1M −66,000 −$5.1M
AIR, Aar 0.03% Exit 0 $109.46 $5M −46,000 −$5M
GTX, Garrett Motion 0.03% Exit 0 $18.17 $5M −275,000 −$5M
ROL, Rollins 0.03% Exit 0 $53.41 $5M −93,000 −$5M
AFRM, Affirm 0.03% Exit 0 $45.82 $4.9M −108,000 −$4.9M
INTR, Inter And 0.03% Exit 0 $7.96 $4.9M −614,500 −$4.9M
CMI, Cummins 0.03% Exit 0 $538.00 $4.8M −9,000 −$4.8M
FISV, Fiserv 0.03% Exit 0 $55.80 $4.8M −86,000 −$4.8M
VRT, Vertiv 0.03% Exit 0 $250.58 $4.8M −19,000 −$4.8M
AMKR, Amkor Technology 0.03% Exit 0 $45.03 $4.7M −104,000 −$4.7M
RNA, Atrium Therapeutics 0.03% Exit 0 $13.37 $4.7M −349,360 −$4.7M
GFS, Globalfoundries 0.03% Exit 0 $44.48 $4.7M −105,000 −$4.7M
MOH, Molina Healthcare 0.03% Exit 0 $133.31 $4.7M −35,000 −$4.7M
IRD, Opus Genetics 0.03% Exit 0 $4.55 $4.6M −1,000,000 −$4.6M
TENB, Tenable 0.03% Exit 0 $16.91 $4.5M −265,000 −$4.5M
NOW, ServiceNow 0.02% Exit 0 $104.56 $4.3M −41,000 −$4.3M
MDGL, Madrigal Pharmaceuticals 0.01% Exit 0 $523.35 $1.7M −3,319 −$1.7M
CAPR 0.01% Exit 0 $30.39 $1.2M −41,000 −$1.2M
ARWR, Arrowhead Pharmaceuticals 0.01% Exit 0 $62.72 $991K −15,800 −$991K
ALKS, Alkermes — Exit 0 $35.34 $735K −20,800 −$735K
AXSM, Axsome Therapeutics — Exit 0 $169.00 $676K −4,000 −$676K
ARQT, Arcutis Biotherapeutics — Exit 0 $23.58 $613K −26,000 −$613K
CELC, Celcuity — Exit 0 $114.25 $457K −4,000 −$457K
LIVN, Livanova — Exit 0 $63.50 $381K −6,000 −$381K
TERN, Terns Pharmaceuticals — Exit 0 $52.71 $369K −7,000 −$369K
IONS, Ionis Pharmaceuticals — Exit 0 $75.00 $360K −4,800 −$360K
TVTX, Travere Therapeutics — Exit 0 $29.75 $357K −12,000 −$357K
GMED, Globus Medical — Exit 0 $86.25 $345K −4,000 −$345K
SRRK, Scholar Rock — Exit 0 $49.14 $344K −7,000 −$344K
ONC, Beone Medicines — Exit 0 $297.27 $327K −1,100 −$327K
WGS, Genedx — Exit 0 $64.20 $321K −5,000 −$321K
COR, Cencora — Exit 0 $314.00 $314K −1,000 −$314K
NUVL, Nuvalent — Exit 0 $102.33 $307K −3,000 −$307K
PGNY, Progyny — Exit 0 $17.00 $306K −18,000 −$306K
STOK, Stoke Therapeutics — Exit 0 $32.56 $293K −9,000 −$293K
ERAS, Erasca — Exit 0 $16.17 $291K −18,000 −$291K
EHC, Encompass Health — Exit 0 $96.67 $290K −3,000 −$290K
NKTR, Nektar Therapeutics — Exit 0 $72.00 $288K −4,000 −$288K
GKOS, Glaukos — Exit 0 $107.69 $280K −2,600 −$280K
MIRM, Mirum Pharmaceuticals — Exit 0 $92.33 $277K −3,000 −$277K
SBRA, Sabra Health Care REIT — Exit 0 $19.21 $269K −14,000 −$269K
KRYS, Krystal Biotech — Exit 0 $258.00 $258K −1,000 −$258K
OMER, Omeros — Exit 0 $10.57 $243K −23,000 −$243K
ALMS, Alumis — Exit 0 $22.00 $242K −11,000 −$242K
APLS, Apellis Pharmaceuticals — Exit 0 $40.17 $241K −6,000 −$241K
HQY, Healthequity — Exit 0 $83.57 $234K −2,800 −$234K
SNDX, Syndax Pharmaceuticals — Exit 0 $23.40 $234K −10,000 −$234K
FOLD, Amicus — Exit 0 $14.44 $231K −16,000 −$231K
QURE, Uniqure — Exit 0 $16.36 $229K −14,000 −$229K
BCRX, Biocryst Pharmaceuticals — Exit 0 $9.50 $228K −24,000 −$228K
GRFS, Grifols — Exit 0 $8.04 $225K −28,000 −$225K
VCYT, Veracyte — Exit 0 $32.14 $225K −7,000 −$225K
GEHC, GE HealthCare — Exit 0 $71.33 $214K −3,000 −$214K
HIMS, Hims & Hers Health — Exit 0 $20.80 $208K −10,000 −$208K
BLTE, Belite Bio — Exit 0 $159.23 $207K −1,300 −$207K
MMSI, Merit Medical Systems — Exit 0 $69.00 $207K −3,000 −$207K
SUPN, Supernus Pharmaceuticals — Exit 0 $51.75 $207K −4,000 −$207K
HR, Healthcare Realty Trust — Exit 0 $17.00 $204K −12,000 −$204K
URGN, Urogen — Exit 0 $18.00 $198K −11,000 −$198K
VIR, Vir Biotechnology — Exit 0 $8.95 $197K −22,000 −$197K
PGEN, Precigen — Exit 0 $3.88 $194K −50,000 −$194K
SDGR, Schrodinger — Exit 0 $11.35 $193K −17,000 −$193K
DYN, Dyne Therapeutics — Exit 0 $18.10 $181K −10,000 −$181K
NVAX, Novavax — Exit 0 $8.14 $179K −22,000 −$179K
SLS — Exit 0 $4.22 $169K −40,000 −$169K
ADPT — Exit 0 $13.91 $153K −11,000 −$153K
OCUL, Ocular Therapeutix — Exit 0 $8.44 $152K −18,000 −$152K
NEO, Neogenomics — Exit 0 $7.42 $141K −19,000 −$141K
ARDX, Ardelyx — Exit 0 $6.00 $138K −23,000 −$138K
OSCR, Oscar Health — Exit 0 $11.45 $126K −11,000 −$126K
NUVB, Nuvation Bio — Exit 0 $4.28 $124K −29,000 −$124K
IOVA, Iovance Biotherapeutics — Exit 0 $3.50 $91K −26,000 −$91K
ALT, Altimmune — Exit 0 $3.08 $85K −27,600 −$85K
CCCC, C4 Therapeutics — Exit 0 $2.64 $74K −28,000 −$74K
TVRD, Tvardi Therapeutics — Exit 0 $3.17 $68K −21,438 −$68K
IRWD, Ironwood Pharmaceuticals — Exit 0 $3.54 $46K −13,000 −$46K
EVH, Evolent Health — Exit 0 $2.29 $32K −14,000 −$32K

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2026 Q1. Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top. Exit opens the last-held block below.

Filings history

20 periods, with AUM normalized

Newest 13Fs
Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 89 $21.7B +23.6% 13F-HR 8/14/2026 000090883426000432
2026 Q1 1 $1.5B — new holds 8/14/2026 000090883426000434
2026 Q1 172 $17.5B −17.2% 13F-HR 5/15/2026 000090883426000240
2025 Q4 1 $1B — new holds 8/14/2026 000090883426000433
2025 Q4 2 $884M — new holds 5/15/2026 000090883426000241
2025 Q4 151 $21.2B −13.2% 13F-HR 2/17/2026 000090883426000087
2025 Q3 144 $24.4B — RESTATEMENT 2/17/2026 000090883426000086
2025 Q3 144 $24.4B +5.4% 13F-HR 11/14/2025 000090883425000353
2025 Q2 1 $140M — new holds 2/17/2026 000090883426000085
2025 Q2 3 $483M — new holds 11/14/2025 000090883425000352
2025 Q2 141 $23.2B +29.2% 13F-HR 8/14/2025 000090883425000248
2025 Q1 1 $274M — new holds 2/17/2026 000090883426000084
2025 Q1 3 $416M — new holds 11/14/2025 000090883425000351
2025 Q1 7 $2.2B — new holds 8/14/2025 000090883425000247
2025 Q1 135 $17.9B −9.0% 13F-HR 5/15/2025 000090883425000177
2024 Q4 1 $85M — new holds 2/17/2026 000090883426000083
2024 Q4 2 $349M — new holds 11/14/2025 000090883425000350
2024 Q4 6 $2.3B — new holds 8/14/2025 000090883425000246
2024 Q4 4 $333M — new holds 5/15/2025 000090883425000180
2024 Q4 138 $19.7B −3.5% 13F-HR 2/14/2025 000090883425000081
2024 Q3 1 $145M — new holds 11/14/2025 000090883425000349
2024 Q3 6 $1.5B — new holds 8/14/2025 000090883425000243
2024 Q3 3 $216M — new holds 5/15/2025 000090883425000179
2024 Q3 2 $544M — new holds 2/14/2025 000090883425000080
2024 Q3 153 $20.4B −3.6% 13F-HR 11/14/2024 000090883424000307
2024 Q2 1 $120M — new holds 11/14/2025 000090883425000348
2024 Q2 5 $1.2B — new holds 8/14/2025 000090883425000245
2024 Q2 1 $199M — new holds 5/15/2025 000090883425000178
2024 Q2 2 $452M — new holds 2/14/2025 000090883425000079
2024 Q2 1 $149M — new holds 11/14/2024 000090883424000324
2024 Q2 157 $21.2B −4.2% 13F-HR 8/14/2024 000090883424000200
2024 Q1 1 $93M — new holds 11/14/2025 000090883425000347
2024 Q1 4 $1.2B — new holds 8/14/2025 000090883425000244
2024 Q1 2 $159M — new holds 2/14/2025 000090883425000078
2024 Q1 1 $45M — new holds 8/14/2024 000090883424000202
2024 Q1 167 $22.1B — RESTATEMENT 5/24/2024 000090883424000159
2024 Q1 167 $22.1B +9.8% 13F-HR 5/15/2024 000090883424000135
2023 Q4 1 $65M — new holds 11/14/2025 000090883425000346
2023 Q4 2 $548M — new holds 8/14/2025 000090883425000250
2023 Q4 5 $1.1B — new holds 5/15/2024 000090883424000141
2023 Q4 150 $20.1B +1.0% 13F-HR 2/14/2024 000090883424000070
2023 Q3 1 $40M — new holds 11/14/2025 000090883425000345
2023 Q3 1 $40M — new holds 5/15/2024 000090883424000138
2023 Q3 2 $1.4B — new holds 2/14/2024 000090883424000077
2023 Q3 1 $1.9B — new holds 2/12/2024 000090883424000049
2023 Q3 159 $20B +11.5% 13F-HR 11/14/2023 000090883423000150
2023 Q2 2 $669M — new holds 2/14/2024 000090883424000076
2023 Q2 5 $1.4B — new holds 11/14/2023 000090883423000157
2023 Q2 1 $1.2B — new holds 10/26/2023 000090883423000134
2023 Q2 165 $17.9B +1.3% 13F-HR 8/14/2023 000090883423000109
2023 Q1 2 $234M — new holds 2/14/2024 000090883424000075
2023 Q1 3 $389M — new holds 11/14/2023 000090883423000156
2023 Q1 1 $15M — new holds 8/14/2023 000090883423000110
2023 Q1 187 $17.7B +15.8% 13F-HR 5/15/2023 000117570723000127
2022 Q4 1 $171M — new holds 2/14/2024 000090883424000074
2022 Q4 3 $485M — new holds 11/14/2023 000090883423000155
2022 Q4 7 $1B — new holds 5/15/2023 000117570723000136
2022 Q4 232 $15.3B −9.3% 13F-HR 2/14/2023 000117570723000051
2022 Q3 1 $125M — new holds 2/14/2024 000090883424000073
2022 Q3 3 $415M — new holds 11/14/2023 000090883423000154
2022 Q3 5 $411M — new holds 5/15/2023 000117570723000135
2022 Q3 4 $434M — new holds 2/14/2023 000090966123000005
2022 Q3 298 $16.8B +3.5% 13F-HR 11/14/2022 000156761922019851
2022 Q2 1 $115M — new holds 2/14/2024 000090883424000081
2022 Q2 3 $411M — new holds 11/14/2023 000090883423000153
2022 Q2 2 $337M — new holds 5/15/2023 000117570723000134
2022 Q2 3 $136M — new holds 2/14/2023 000090966123000003
2022 Q2 9 $1.2B — new holds 11/14/2022 000156761922019862
2022 Q2 297 $16.3B −13.7% 13F-HR 8/15/2022 000156761922015953
2022 Q1 1 $268M — new holds 11/14/2023 000090883423000152
2022 Q1 1 $314M — new holds 5/15/2023 000117570723000133
2022 Q1 1 $27M — new holds 2/14/2023 000090966123000002
2022 Q1 3 $186M — new holds 11/14/2022 000156761922019864
2022 Q1 8 $1.1B — new holds 8/15/2022 000156761922015972
2022 Q1 307 $18.8B +0.4% 13F-HR 5/16/2022 000156761922010736
2021 Q4 1 $227M — new holds 5/15/2023 000117570723000132
2021 Q4 1 $7M — new holds 11/14/2022 000156761922019852
2021 Q4 1 $115M — new holds 8/15/2022 000156761922015968
2021 Q4 2 $98M — new holds 5/19/2022 000156761922011257
2021 Q4 6 $833M — new holds 5/16/2022 000156761922010757
2021 Q4 289 $18.7B −5.1% 13F-HR 2/14/2022 000156761922003965
2021 Q3 1 $182M — new holds 5/15/2023 000117570723000131
2021 Q3 1 $105M — new holds 8/15/2022 000156761922015964
2021 Q3 1 $57M — new holds 5/19/2022 000156761922011256
2021 Q3 3 $998M — new holds 5/16/2022 000156761922010753
2021 Q3 2 $344M — new holds 2/14/2022 000156761922003981
2021 Q3 293 $19.7B — 13F-HR 11/15/2021 000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name
FARALLON CAPITAL MANAGEMENT, L.L.C.
Location
San Francisco, CA
All SEC filings
View on sec.gov